IL6 and fatty liver disease: In addition, they produced IL-6-KO mice and found that IL-6-KO mice reduced the browning of WAT by inhibiting STAT3 phosphorylation, accompanied by disturbed glucose homeostasis and accelerated hepatic steatosis.